Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
12 February 2021Website:
http://talisbio.comNext earnings report:
21 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 20 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
TLIS Latest News
Talis Biomedical Corporation (NASDAQ:TLIS ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Emily Faucette - Senior Vice President, Corporate Communications & Investor Relations Rob Kelley - Chief Executive Officer Becky Markovich - Interim Chief Financial Officer Conference Call Participants Mark Massaro - BTIG Operator Good day and thank you for standing by. Welcome to the Talis Biomedical's Business Update Conference Call.
What type of business is Talis Biomedical?
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
What sector is Talis Biomedical in?
Talis Biomedical is in the Healthcare sector
What industry is Talis Biomedical in?
Talis Biomedical is in the Medical Devices industry
What country is Talis Biomedical from?
Talis Biomedical is headquartered in United States
When did Talis Biomedical go public?
Talis Biomedical initial public offering (IPO) was on 12 February 2021
What is Talis Biomedical website?
https://talisbio.com
Is Talis Biomedical in the S&P 500?
No, Talis Biomedical is not included in the S&P 500 index
Is Talis Biomedical in the NASDAQ 100?
No, Talis Biomedical is not included in the NASDAQ 100 index
Is Talis Biomedical in the Dow Jones?
No, Talis Biomedical is not included in the Dow Jones index
When was Talis Biomedical the previous earnings report?
No data
When does Talis Biomedical earnings report?
The next expected earnings date for Talis Biomedical is 21 November 2024